MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.130 -0.050 (-4.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
Top 3 Health Care Stocks That Could Blast Off This Month ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals ↗
 
Via Benzinga
News headline image
A Preview Of Inovio Pharmaceuticals's Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
News headline image
8 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript ↗
INO earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For March 18, 2025 ↗
 
Via Benzinga
News headline image
What's Going On With Inovio Pharmaceuticals (INO) Stock? ↗
Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday's session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses. 
Via Benzinga
News headline image
The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
Why Inovio Pharmaceuticals (INO) Stock Is Skyrocketing ↗
Inovio Pharmaceuticals shares are trading higher by 20.7% Tuesday afternoon. Vaccine stocks are rising amid growing concerns about respiratory illnesses. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet ↗
 
Via Benzinga
News headline image
Crude Oil Gains Over 1%; RH Shares Jump On Strong Forecast ↗
 
Via Benzinga
News headline image
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings ↗
 
Via Benzinga
News headline image
Why Inovio Pharmaceuticals (INO) Stock Is Down 40% ↗
Inovio Pharmaceuticals shares are trading lower by 38% during Friday's session. The company priced a public offering of 10 million shares of common stock and accompanying warrants. 
Via Benzinga
News headline image
US Stocks Likely To Open Higher, Investors Eye Fed Policy Meet Next Week: Broadcom, RH, Costco In Focus ↗
U.S. stock futures advanced on Friday in premarket after declining on Thursday. The futures of all four major indices were trading higher. 
Via Benzinga
Topics Economy
News headline image
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
RH, Broadcom And 3 Stocks To Watch Heading Into Friday ↗
 
Via Benzinga
News headline image
European And US Vaccine Stocks Are Under Pressure - Here's WHy ↗
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts. 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript ↗
INO earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Earnings Scheduled For November 14, 2024 ↗
 
Via Benzinga
News headline image
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
From FN Media Group LLC
Via GlobeNewswire
News headline image
Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript ↗
INO earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
INO stock results show that Inovio Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Better Buy: Inovio Pharmaceuticals vs. Novavax ↗
Both biotechs have been struggling for a while, but there might be some hope for them. 
Via The Motley Fool
News headline image
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story